Clinical trial
A Study of Patients With HER2-Positive Metastatic Breast Cancer
NCT00105456 · Genentech, Inc., Industry · Completed
Key facts
| NCT number | NCT00105456 |
|---|---|
| Title | A Study of Patients With HER2-Positive Metastatic Breast Cancer |
| Official title | registHER: An Observational Cohort Study of Patients With HER2 Positive Metastatic Breast Cancer |
| Lead sponsor | Genentech, Inc., Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Breast Cancer |
| Enrollment | 1,000 |
| Start date | Mar 1, 2003 |
| Completion | May 1, 2009 |
| First posted | Mar 15, 2005 |
| Last update posted | May 6, 2010 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: